In their 2019 JAMA article "Reconsidering the Consequences of Using Race to Estimate Kidney Function," Eneanya et al. posit that using race to guide clinical care is justified only if:
(1) the use confers substantial benefit;
(2) the benefit cannot be achieved through other feasible approaches;
(3) patients who reject race categorization are accommodated fairly; and
(4) the use of race is transparent.
Has anyone encountered an example of the use of race in clinical care that meets these criteria? How can providers and institutions be more transparent about the use of race in eGFR calculation or other clinical algorithms? How might shared decision-making be employed to lend patients agency in the use of race in their clinical care?
Eneanya ND, Yang W, Reese PP. Reconsidering the Consequences of Using Race to Estimate Kidney Function. Jama. 2019;322(2):113. doi:10.1001/jama.2019.5774
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.